• United States

U.S. Biotech Stocks Analysis

NasdaqGM:TVTX
NasdaqGM:TVTX
NasdaqGM:TVTXBiotechs

Don't Ignore The Fact That This Insider Just Sold Some Shares In Travere Therapeutics, Inc. (NASDAQ:TVTX)

May 15, 2022
Investors may wish to note that the Director of Travere Therapeutics, Inc. , Stephen Aselage, recently netted US$56k...
NasdaqGS:INSM
NasdaqGS:INSM
NasdaqGS:INSMBiotechs

Trade Alert: The Independent Director Of Insmed Incorporated (NASDAQ:INSM), Melvin Sharoky, Has Just Spent US$344k Buying 8.7% More Shares

May 15, 2022
Potential Insmed Incorporated ( NASDAQ:INSM ) shareholders may wish to note that the Independent Director, Melvin...
NasdaqGM:XENE
NasdaqGM:XENE
NasdaqGM:XENEBiotechs

Xenon Pharmaceuticals (NASDAQ:XENE) delivers shareholders fantastic 49% CAGR over 5 years, surging 9.4% in the last week alone

May 15, 2022
It might be of some concern to shareholders to see the Xenon Pharmaceuticals Inc. ( NASDAQ:XENE ) share price down 12...
NasdaqGS:VERV
NasdaqGS:VERV
NasdaqGS:VERVBiotechs

Insider Buying: The Verve Therapeutics, Inc. (NASDAQ:VERV) Independent Chairman of the Board Just Bought 2.4% More Shares

May 15, 2022
Potential Verve Therapeutics, Inc. ( NASDAQ:VERV ) shareholders may wish to note that the Independent Chairman of the...
NasdaqGS:IMUX
NasdaqGS:IMUX
NasdaqGS:IMUXBiotechs

Executive Chairman Duane Nash Just Bought 166% More Shares In Immunic, Inc. (NASDAQ:IMUX)

May 15, 2022
Whilst it may not be a huge deal, we thought it was good to see that the Immunic, Inc. ( NASDAQ:IMUX ) Executive...
NasdaqGS:PSTX
NasdaqGS:PSTX
NasdaqGS:PSTXBiotechs

Earnings Release: Here's Why Analysts Cut Their Poseida Therapeutics, Inc. (NASDAQ:PSTX) Price Target To US$16.25

May 15, 2022
It's been a sad week for Poseida Therapeutics, Inc. ( NASDAQ:PSTX ), who've watched their investment drop 12% to...
NasdaqGM:ACET
NasdaqGM:ACET
NasdaqGM:ACETBiotechs

Results: Adicet Bio, Inc. Confounded Analyst Expectations With A Surprise Profit

May 15, 2022
There's been a major selloff in Adicet Bio, Inc. ( NASDAQ:ACET ) shares in the week since it released its first-quarter...
NasdaqGS:CYT
NasdaqGS:CYT
NasdaqGS:CYTBiotechs

Insider Buying: The Cyteir Therapeutics, Inc. (NASDAQ:CYT) Independent Investor & Independent Chairman of the Board Just Bought 17% More Shares

May 15, 2022
Even if it's not a huge purchase, we think it was good to see that Joseph Zakrzewski, the Independent Investor...
NasdaqGS:TWST
NasdaqGS:TWST
NasdaqGS:TWSTBiotechs

Independent Non-Employee Director Nicholas Barthelemy Just Bought 159% More Shares In Twist Bioscience Corporation (NASDAQ:TWST)

May 15, 2022
Investors who take an interest in Twist Bioscience Corporation ( NASDAQ:TWST ) should definitely note that the...
Last
  • 3
  • 4
  • 5
  • 6
  • 7
Next

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.

Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
  • About
  • Company
  • Careers
  • Plans
  • Log In
  • Help Centre
  • Latest Coverage
  • Podcasts
  • Financial Services Guide
  • Terms and Conditions
  • Privacy Policy

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.